Enhanced sensitivity method for measuring gemcitabine in human plasma

Amit Khatri; James E. Fisher; Mark N. Kirstein

doi:10.1365/s10337-010-1751-2

Enhanced sensitivity method for measuring gemcitabine in human plasma

Amit Khatri, James E. Fisher, Mark N. Kirstein

Experimental and Clinical Pharmacology

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

A simple and reliable method for the separation and sensitive quantitation of gemcitabine in human plasma was developed. Samples were concentrated and purified with solid phase extraction. Extracts were then injected onto Spherisorb 4.6 mm × 150 mm, 3 μm ODS2 column, and isocratically eluted with mobile phase containing 11 mM 1-octanesulfonate sodium as ion pairing agent. The assay was validated and intermediate precision (% CV_t) was ≤6.40%. The assay was linear over a concentration range from 0.01 to 50 μM, and the lower limit of quantitation (LLOQ) was 0.01 μM. Solid phase extraction has enabled achievement of sensitivity which is at least 20-fold less than that reported for other LC assays, and is comparable to MS-MS.

Original language	English (US)
Pages (from-to)	1005-1008
Number of pages	4
Journal	Chromatographia
Volume	72
Issue number	9-10
DOIs	https://doi.org/10.1365/s10337-010-1751-2
State	Published - Nov 2010

Keywords

Column Liquid Chromatography
Gemcitabine in human plasma
Pharmacokinetic study
Solid phase extraction

Access

10.1365/s10337-010-1751-2

OpenUrl availability

Full text

Cite this

@article{dd8941560588468a8de0462df4d9d15d,

title = "Enhanced sensitivity method for measuring gemcitabine in human plasma",

abstract = "A simple and reliable method for the separation and sensitive quantitation of gemcitabine in human plasma was developed. Samples were concentrated and purified with solid phase extraction. Extracts were then injected onto Spherisorb 4.6 mm × 150 mm, 3 μm ODS2 column, and isocratically eluted with mobile phase containing 11 mM 1-octanesulfonate sodium as ion pairing agent. The assay was validated and intermediate precision (% CVt) was ≤6.40%. The assay was linear over a concentration range from 0.01 to 50 μM, and the lower limit of quantitation (LLOQ) was 0.01 μM. Solid phase extraction has enabled achievement of sensitivity which is at least 20-fold less than that reported for other LC assays, and is comparable to MS-MS.",

keywords = "Column Liquid Chromatography, Gemcitabine in human plasma, Pharmacokinetic study, Solid phase extraction",

author = "Amit Khatri and Fisher, {James E.} and Kirstein, {Mark N.}",

year = "2010",

month = nov,

doi = "10.1365/s10337-010-1751-2",

language = "English (US)",

volume = "72",

pages = "1005--1008",

journal = "Chromatographia",

issn = "0009-5893",

publisher = "Springer Vieweg",

number = "9-10",

}

TY - JOUR

T1 - Enhanced sensitivity method for measuring gemcitabine in human plasma

AU - Khatri, Amit

AU - Fisher, James E.

AU - Kirstein, Mark N.

PY - 2010/11

Y1 - 2010/11

N2 - A simple and reliable method for the separation and sensitive quantitation of gemcitabine in human plasma was developed. Samples were concentrated and purified with solid phase extraction. Extracts were then injected onto Spherisorb 4.6 mm × 150 mm, 3 μm ODS2 column, and isocratically eluted with mobile phase containing 11 mM 1-octanesulfonate sodium as ion pairing agent. The assay was validated and intermediate precision (% CVt) was ≤6.40%. The assay was linear over a concentration range from 0.01 to 50 μM, and the lower limit of quantitation (LLOQ) was 0.01 μM. Solid phase extraction has enabled achievement of sensitivity which is at least 20-fold less than that reported for other LC assays, and is comparable to MS-MS.

AB - A simple and reliable method for the separation and sensitive quantitation of gemcitabine in human plasma was developed. Samples were concentrated and purified with solid phase extraction. Extracts were then injected onto Spherisorb 4.6 mm × 150 mm, 3 μm ODS2 column, and isocratically eluted with mobile phase containing 11 mM 1-octanesulfonate sodium as ion pairing agent. The assay was validated and intermediate precision (% CVt) was ≤6.40%. The assay was linear over a concentration range from 0.01 to 50 μM, and the lower limit of quantitation (LLOQ) was 0.01 μM. Solid phase extraction has enabled achievement of sensitivity which is at least 20-fold less than that reported for other LC assays, and is comparable to MS-MS.

KW - Column Liquid Chromatography

KW - Gemcitabine in human plasma

KW - Pharmacokinetic study

KW - Solid phase extraction

UR - http://www.scopus.com/inward/record.url?scp=78149410695&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78149410695&partnerID=8YFLogxK

U2 - 10.1365/s10337-010-1751-2

DO - 10.1365/s10337-010-1751-2

M3 - Article

AN - SCOPUS:78149410695

SN - 0009-5893

VL - 72

SP - 1005

EP - 1008

JO - Chromatographia

JF - Chromatographia

IS - 9-10

ER -

Enhanced sensitivity method for measuring gemcitabine in human plasma

Abstract

Keywords

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this